Tirzepatide Bests Semaglutide in 12-Month Real-World Study

Published Date: 14 Apr 2026

Tirzepatide is associated with a greater mean percent body weight reduction than semaglutide in adults with obesity or overweight and one or more related complications.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Study: Rapamycin slows the progression of cancer by reducing aging and concentrating on precancerous cells.

2.

Can Alternating Venetoclax Regimens Improve AML Outcomes?

3.

Cancer detection recovered following pandemic disruptions

4.

COVID-19 mRNA vaccines could unlock the next revolution in cancer treatment

5.

Research identifies nearly 200 potential breast carcinogens in food packaging materials


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot